FindTrial
Sign In

Presepsin for sepsis diagnosis

Presepsin for the detection and risk stratification of sepsis in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/10/016077
Enrollment
30
Registered
2018-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A419- Sepsis, unspecified organism

Interventions

Intervention1: None: None Control Intervention1: None: None

Sponsors

All India Institute of Medical Sciences Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All children aged 3 months to 18 years. 2. Clinical data to enable classification into sepsis or SIRS 3. Written informed consent by the legally authorized representative

Exclusion criteria

Exclusion criteria: No informed consent

Design outcomes

Primary

MeasureTime frame
To assess the diagnostic accuracy of presepsin in diagnosing sepsis in children and in discriminating systemic inflammatory response syndrome (SIRS) from sepsis.Timepoint: At admission and after 72 hours—

Secondary

MeasureTime frame
To assess the prognostic accuracy of presepsin compared to currently available infection biomarkersTimepoint: Blood samples will be collected for estimation of presepsin, procalcitonin (PCT) and high sensitivity C reactive protein (hsCRP)at admission and after 72 hours—

Countries

India

Contacts

Public ContactDr Daisy Khera

All India Institute of Medical Sciences Jodhpur

daisykhera78@gmail.com8003996913

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026